Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal vaccines for preventing otitis media.

M Straetemans1, E A Sanders, R H Veenhoven

  • 1Department of Epidemiology and Biostatistics, UMC Nijmegen, Geert Grooteplein 21, Nijmegen, Netherlands, 6525 EZ. M.Straetemans@mie.kun.nl

The Cochrane Database of Systematic Reviews
|June 22, 2002
PubMed
Summary

Pneumococcal vaccination shows limited effectiveness in preventing acute otitis media (AOM) in children. Large-scale vaccination for AOM prevention is not currently recommended, pending further research on high-risk groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of the COVID-19 pandemic on healthcare access and utilisation in South Sudan: a cross-sectional mixed methods study.

BMC health services research·2022
Same author

Increasing TB/HIV Case Notification through an Active Case-Finding Approach among Rural and Mining Communities in Northwest Tanzania.

Journal of tropical medicine·2022
Same author

Correlates of observing and willingness to report stigma towards HIV clients by (TB) health workers in Africa.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Should active case-finding projects increase the number of tuberculosis cases notified at national level?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Point-of-care management of urogenital Chlamydia trachomatis via Gram-stained smear analysis in male high-risk patients. Diagnostic accuracy and cost-effectiveness before and after changing the screening indication at the STI Clinic in Amsterdam.

Sexually transmitted infections·2015
Same author

Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam.

Sexually transmitted infections·2014

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Acute otitis media (AOM) is a common childhood illness with significant long-term effects.
  • Recurrent AOM, drug-resistant bacteria, and high costs necessitate effective prevention strategies.
  • Vaccination is a key strategy for preventing AOM episodes.

Purpose of the Study:

  • To review the efficacy of pneumococcal vaccination in preventing AOM in children up to 12 years old.

Main Methods:

  • Searched major databases (Cochrane, MEDLINE) and contacted manufacturers and authors.
  • Included randomized controlled trials of pneumococcal vaccination with AOM prevention as the outcome.
  • Five reviewers assessed trial quality and extracted data.

Related Experiment Videos

Main Results:

  • Pneumococcal polysaccharide vaccine (PPV) showed highest efficacy in children aged 24 months and older (RR 0.833).
  • PPV had limited effect on preventing AOM in children without prior episodes and moderate effect in those with prior AOM.
  • Two pneumococcal conjugate vaccine (PCV) trials in infants showed a 9% decrease in recurrent disease risk (RR 0.91 and 0.90).

Conclusions:

  • Large-scale pneumococcal vaccination for AOM prevention is not recommended based on current evidence.
  • Ongoing trials may provide further insights into vaccine effectiveness in specific high-risk (otitis-prone) populations.